Apolipoprotein B and Nuclear Magnetic Resonance Particle Number

To the Editor: In the recent special report on the assessment of apolipoprotein B (apoB)1 and nuclear magnetic resonance particle number (1), the authors recommended that measurement of particle number be incorporated into the guidelines for the assessment of cardiovascular disease (CVD) risk. However, the literature reviewed provides no basis for this recommendation. Searching the literature using the key terms apo B and LDL-P (LDL particle number) and the name …